المؤلفون: Liddicoat, Johnathon, Hamidzadeh, Ashleigh, Liddell, Kathleen, Aboy, Mateo

المساهمون: Novo Nordisk Fonden

المصدر: The Journal of World Intellectual Property ; ISSN 1422-2213 1747-1796

الاتاحة: http://dx.doi.org/10.1111/jwip.12327
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jwip.12327

المؤلفون: Hamidzadeh, Ashleigh, Liddicoat, Johnathon, Liddell, Kathleen

المصدر: Hamidzadeh , A , Liddicoat , J & Liddell , K 2023 , ' Should Europe Adopt a Policy Like the US FDA’s Project Renewal? ' , European Health and Pharmaceutical Law Review , vol. 7 , no. 3 , pp. 126-128 . https://doi.org/10.21552/ehpl/2023/3/6

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الاتاحة: https://kclpure.kcl.ac.uk/portal/en/publications/6e377d3c-dd2b-4198-bd36-53accd8daf00
https://doi.org/10.21552/ehpl/2023/3/6
https://kclpure.kcl.ac.uk/ws/files/243923288/Should_Europe_Adopt_a_Policy_Like_the_US_FDA_s_Project_Renewal_EHPL_.docx
http://www.scopus.com/inward/record.url?scp=85178956862&partnerID=8YFLogxK

المؤلفون: Liddicoat, Johnathon, Hamidzadeh, Ashleigh, Liddell, Kathleen, Schito, Marco, Simon, David, Aboy, Mateo, Minssen, Timo

المصدر: Science Translational Medicine; 6/26/2024, Vol. 16 Issue 753, p1-4, 4p

مصطلحات موضوعية: DRUG repositioning, DRUG development, INTELLECTUAL property

المؤلفون: Liddicoat, Johnathan, Hamidzadeh , Ashleigh, Liddell, Kathleen, Schito, Marco, Simon, David, Aboy, Mateo, Minssen, Timo

المصدر: Liddicoat , J , Hamidzadeh , A , Liddell , K , Schito , M , Simon , D , Aboy , M & Minssen , T 2024 , ' New drug-development paradigms? Opportunities and uncertainties with new government drug repurposing programmes ' , Science Translational Medicine , vol. 16 , no. 753 . https://doi.org/10.1126/scitranslmed.adl0998

مصطلحات موضوعية: /dk/atira/pure/core/keywords/TheFacultyOfLaw, Faculty of Law, Government Programs, drug R&D, new uses, drug repurposing, Public private partnership, Emperical legal studies

الاتاحة: https://curis.ku.dk/portal/da/publications/new-drugdevelopment-paradigms-opportunities-and-uncertainties-with-new-government-drug-repurposing-programmes(ecb193fe-3318-40e1-a114-80d5d8ad6d2f).html
https://doi.org/10.1126/scitranslmed.adl0998
https://www.science.org/doi/10.1126/scitranslmed.adl0998?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

المؤلفون: Hamidzadeh, Ashleigh, Liddicoat, Johnathon, Liddell, Kathleen

المصدر: European Health & Pharma Law Review. 2023, Vol. 7 Issue 1, p36-38. 3p.

مصطلحات موضوعية: *DRUG patents, *DRUG labeling, *CONTRACTS, GENERIC drugs, DRUG approval laws, DRUG repositioning

الشركة/الكيان: UNITED States. Food & Drug Administration